ChoiSRHowellOWCarassitiD. Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis. Brain2012; 135: 2925–2937.
2.
LisakRPBenjaminsJANedelkoskaL. Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro. J Neuroimmunol2012; 246: 85–95.
3.
Von BudingenHCKuoTCSirotaM. B cell exchange across the blood-brain barrier in multiple sclerosis. J Clin Invest2012; 122: 4533–4543.
4.
FischerMTSharmaRLimJL. NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain2012; 135: 886–899.
5.
LucchinettiCBruckWParisiJScheithauerBRodriguezMLassmannH. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann Neurol2000; 47: 707–717.
6.
CaprarielloAVManglaSMillerRHSelkirkSM. Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination. Ann Neurol2012; 72: 395–405.
7.
TrakaMArasiKAvilaRL. A genetic mouse model of adult-onset, pervasive central nervous system demyelination with robust remyelination. Brain2010; 133: 3017–3029.
8.
PohlHBPorcheriCMuegglerT. Genetically induced adult oligodendrocyte cell death is associated with poor myelin clearance, reduced remyelination, and axonal damage. J Neurosci2011; 31: 1069–1080.
9.
ChangAStaugaitisSMDuttaR. Cortical remyelination: A new target for repair therapies in multiple sclerosis. Ann Neurol2012; 72: 918–926.
10.
RuckhJMZhaoJWShadrachJL. Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell2012; 10: 96–103.
